These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 18077476)

  • 1. Topiramate, nutrition and weight change: a prospective study.
    Klein KM; Theisen F; Knake S; Oertel WH; Hebebrand J; Rosenow F; Hamer HM
    J Neurol Neurosurg Psychiatry; 2008 May; 79(5):590-3. PubMed ID: 18077476
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictors of weight loss in adults with topiramate-treated epilepsy.
    Ben-Menachem E; Axelsen M; Johanson EH; Stagge A; Smith U
    Obes Res; 2003 Apr; 11(4):556-62. PubMed ID: 12690085
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Changes of body weight and galanin in epileptic children treated with topiramate].
    Shi RF; Wang KL; Li QH; Zheng HC; Yang HF; Tang HX; Sun SZ; Wang LH; Tian J
    Zhonghua Er Ke Za Zhi; 2007 Mar; 45(3):199-202. PubMed ID: 17504624
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes in body mass index during long-term topiramate therapy in paediatric epilepsy patients--a retrospective analysis.
    Reiter E; Feucht M; Hauser E; Freilinger M; Seidl R
    Seizure; 2004 Oct; 13(7):491-3. PubMed ID: 15324828
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of topiramate on energy balance in obese men: a 6-month double-blind randomized placebo-controlled study with a 6-month open-label extension.
    Tremblay A; Chaput JP; Bérubé-Parent S; Prud'homme D; Leblanc C; Alméras N; Després JP
    Eur J Clin Pharmacol; 2007 Feb; 63(2):123-34. PubMed ID: 17200837
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Topiramate-induced weight loss depends on level of intellectual disability in patients with epilepsy.
    Iwaki H; Jin K; Fujikawa M; Nakasato N; Kaneko S
    Epilepsy Behav; 2018 Jun; 83():87-91. PubMed ID: 29665571
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Weight regain after discontinuation of topiramate treatment in patients with migraine: a prospective observational study.
    Verrotti A; Parisi P; Agostinelli S; Loiacono G; Marra F; Coppola G; Pisani LR; Gorgone G; Striano P; Pisani F; Belcastro V
    CNS Drugs; 2015 Feb; 29(2):163-9. PubMed ID: 25655110
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Time course of adverse events in patients with localization-related epilepsy receiving topiramate added to carbamazepine.
    Majkowski J; Neto W; Wapenaar R; Van Oene J
    Epilepsia; 2005 May; 46(5):648-53. PubMed ID: 15857429
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Topiramate weight loss in migraine patients.
    Alberici A; Borroni B; Manelli F; Griffini S; Zavarise P; Padovani A; Dalla Volta G
    J Neurol Sci; 2009 Mar; 278(1-2):64-5. PubMed ID: 19084843
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Topiramate-induced weight loss: a review.
    Verrotti A; Scaparrotta A; Agostinelli S; Di Pillo S; Chiarelli F; Grosso S
    Epilepsy Res; 2011 Aug; 95(3):189-99. PubMed ID: 21684121
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of appetite-stimulating hormones in prepubertal children with epilepsy during topiramate treatment.
    Okuyaz C; Kursel O; Komur M; Tamer L
    Pediatr Neurol; 2012 Dec; 47(6):423-6. PubMed ID: 23127262
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Topiramate and psychiatric adverse events in patients with epilepsy.
    Mula M; Trimble MR; Lhatoo SD; Sander JW
    Epilepsia; 2003 May; 44(5):659-63. PubMed ID: 12752464
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Add-on topiramate reduces weight in overweight patients with affective disorders: a clinical case series.
    Kirov G; Tredget J
    BMC Psychiatry; 2005 Apr; 5():19. PubMed ID: 15817130
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety of topiramate in refractory epilepsy of childhood: long-term follow-up study.
    Grosso S; Franzoni E; Iannetti P; Incorpora G; Cardinali C; Toldo I; Verrotti A; Caterina Moscano F; Lo Faro V; Mazzone L; Zamponi N; Boniver C; Spalice A; Parisi P; Morgese G; Balestri P
    J Child Neurol; 2005 Nov; 20(11):893-7. PubMed ID: 16417859
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy, tolerability, and safety of rapid initiation of topiramate versus phenytoin in patients with new-onset epilepsy: a randomized double-blind clinical trial.
    Ramsay E; Faught E; Krumholz A; Naritoku D; Privitera M; Schwarzman L; Mao L; Wiegand F; Hulihan J;
    Epilepsia; 2010 Oct; 51(10):1970-7. PubMed ID: 20633037
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Topiramate in add-on therapy: results from an open-label, observational study.
    Krakow K; Lengler U; Rettig K; Schreiner A; Schauble B;
    Seizure; 2007 Oct; 16(7):593-600. PubMed ID: 17543544
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Conversion from valproic acid onto topiramate in adolescents and adults with epilepsy.
    Schreiner A; Stollhoff K; Ossig W; Unkelbach S; Lüer W; Bogdanow M; Schauble B;
    Acta Neurol Scand; 2009 May; 119(5):304-12. PubMed ID: 19133865
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Weight loss associated with topiramate treatment].
    Maciá- Bobes C; Cortejoso-García R; Carrio-Montes I; Arias Rodríguez M
    Rev Neurol; 2002 Feb 16-28; 34(4):397. PubMed ID: 12022061
    [No Abstract]   [Full Text] [Related]  

  • 19. Impaired verbal fluency under topiramate--evidence for synergistic negative effects of epilepsy, topiramate, and polytherapy.
    Witt JA; Elger CE; Helmstaedter C
    Eur J Neurol; 2013 Jan; 20(1):130-7. PubMed ID: 22827489
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The longer-term cognitive effects of adjunctive antiepileptic treatment with lacosamide in comparison with lamotrigine and topiramate in a naturalistic outpatient setting.
    Helmstaedter C; Witt JA
    Epilepsy Behav; 2013 Feb; 26(2):182-7. PubMed ID: 23318473
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.